In this section, the current efforts intending to ameliorate IBD by restoring 5-HT signaling through the administration of peripheral TpH1 inhibitors and selective serotonin reuptake inhibitors (SSRIs) will be described. This evidence concerns the gene TPH1 and inflammatory bowel disease.